Literature DB >> 10583082

Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins.

G G Tóth, M F Jonkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10583082     DOI： 10.1046/j.1365-2133.1999.03071.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.

Authors:  S Jolles
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 2.  Intravenous immunoglobulin for treatment of pemphigus.

Authors:  Lehavit Akerman; Daniel Mimouni; Michael David
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  The Treatment of Lyell'S Syndrome: our Experience.

Authors:  B Napoli; N D'Arpa; M Masellis
Journal:  Ann Burns Fire Disasters       Date:  2006-03-31

Review 4.  High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.

Authors:  Norito Ishii; Takashi Hashimoto; Detlef Zillikens; Ralf J Ludwig
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

5.  Pemphigus Vulgaris Associated with Rheumatoid Arthritis in a Patient not Taking Penicillamine.

Authors:  Narges Gholizadeh; Ali Taghavi Zenouz; Hossein Eslami
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2012-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.